What are the effects of long-term Cannabidiol (CBD) use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2025 • View editorial policy

From the Guidelines

Long-term CBD-only use is generally considered safe for most adults, but caution is warranted due to potential liver enzyme elevation and drug-induced liver injury, particularly at high doses above 300 mg/day. When considering long-term CBD use, it is essential to weigh the potential benefits against the risks, prioritizing morbidity, mortality, and quality of life as outcomes. According to the ASCO guideline 1, the pooled proportion of elevated liver enzymes was 0.07 (95% CI, 0.05 to 0.12), whereas the pooled proportion of those with drug-induced liver injury was 0.03 (95% CI, 0.10 to 0.06).

Some key points to consider when using CBD long-term include:

  • Monitoring liver enzymes, especially when using high doses, as dose-related, reversible transaminase elevations have been reported 1
  • Starting with a low dose (5-10mg) and gradually increasing until the minimum effective dose is found
  • Taking CBD consistently, preferably with fatty foods to improve absorption
  • Being aware of potential side effects, such as fatigue, diarrhea, appetite changes, and potential drug interactions with medications metabolized by cytochrome P450 enzymes
  • Choosing high-quality products with third-party testing to verify CBD content and confirm the absence of contaminants

It is also crucial to consider the potential long-term side effects of CBD use, including:

  • Psychiatric risks, such as an increased risk for developing depressive disorders and exacerbating psychiatric disorders in vulnerable individuals 1
  • Cardiovascular side effects, such as arrhythmias and orthostatic hypotension, although there is no evidence that cumulative lifetime use is associated with a higher incidence of cardiovascular disease or associated mortality 1
  • Respiratory risks, although conflicting data exist regarding cannabis use and respiratory disease, often confounded by concomitant nicotine use 1

Ultimately, consulting a healthcare provider before starting CBD, especially if taking other medications or having existing health conditions, is essential to ensure safe and effective use.

From the Research

Long-Term CBD Use

  • Long-term use of CBD has been studied in various contexts, including its potential therapeutic effects on neurological disorders such as epilepsy, multiple sclerosis, Parkinson's disease, and Alzheimer's disease 2, 3, 4.
  • CBD has been shown to have a favorable safety and abuse liability profile, with no acute psychotropic effects 2.
  • Studies have demonstrated CBD's potential to improve cognition and neurogenesis, although more research is needed to determine its effectiveness as a monotherapy for cognitive dysfunction 2.

Therapeutic Effects

  • CBD has been found to have significant therapeutic effects on epilepsy and Parkinson's disease, with potential applications in the treatment of other neurological disorders 3, 4.
  • The neuroprotective effects of CBD may be related to its interaction with the endocannabinoid system and other molecular targets, such as the 5-HT1A receptor 3.
  • CBD has also been shown to have anxiolytic effects, with potential applications in the management of anxiety disorders 5.

Safety and Efficacy

  • CBD has been generally well-tolerated in studies, with minimal adverse effects reported, such as fatigue and sedation 5, 6.
  • However, more research is needed to determine the optimal dosing strategy for CBD and its place in therapy for various neurological disorders 2, 5, 6.
  • Clinical evidence for the effectiveness of CBD in multiple sclerosis is limited, and further studies are needed to fully understand its potential therapeutic effects 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Use of cannabidiol in anxiety and anxiety-related disorders.

Journal of the American Pharmacists Association : JAPhA, 2020

Research

Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.